Nyxoah SA

NYXH

BE0974358906

Advanced Medical Equipment & Technology

Market Closed - Euronext Bruxelles Other stock markets 11:36:19 2024-05-08 am EDT			5-day change	1st Jan Change
8.4 ^EUR	-3.00%		-9.87%	+97.18%

Apr. 12	Nyxoah Names New Chief Medical Officer	MT
Apr. 12	Nyxoah S.A. Appoints Maurits Boon as Chief Medical Officer	CI

Nyxoah S.A.(NasdaqGM:NYXH) added to NASDAQ Composite Index

July 06, 2021 at 12:00 am EDT

Nyxoah S.A. Added to NASDAQ Composite Index

Latest news about Nyxoah SA

Nyxoah Names New Chief Medical Officer	Apr. 12	MT
Nyxoah S.A. Appoints Maurits Boon as Chief Medical Officer	Apr. 11	CI
Nyxoah Appoints Maurits Boon as Chief Medical Officer	Apr. 11	MT
Top Premarket Decliners	Apr. 11	MT
Nyxoah Partners With Medical Association to Lobby Insurers and Regulators	Mar. 25	MT
Global markets live: Super Micro Computer, Boeing, Vale, Tesla, Nvidia, Intel, Nasdaq...	Mar. 20
Stifel Adjusts Nyxoah's Price Target to $27 From $20, Keeps Buy Rating	Mar. 20	MT
HC Wainwright Raises Nyxoah Price Target to $22 From $18, Maintains Buy Rating	Mar. 20	MT
Nyxoah Says US Study of Genio System for Sleep Apnea Reaches Primary Endpoints	Mar. 19	MT
Oppenheimer Adjusts Nyxoah Price Target to $20 From $17, Maintains Outperform Rating	Mar. 14	MT
Piper Sandler Raises Nyxoah's Price Target to $20 From $15, Maintains Overweight Rating	Mar. 06	MT
Oppenheimer Adjusts Nyxoah Price Target to $17 From $12, Maintains Outperform Rating	Mar. 06	MT
Nyxoah S.A. Provides Earnings Guidance for the First Quarter of 2024	Mar. 05	CI
Transcript : Nyxoah S.A., Q4 2023 Earnings Call, Mar 05, 2024	Mar. 05
Nyxoah S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 05	CI
Stifel Raises Price Target on Nyxoah to $20 From $10, Maintains Buy Rating	Mar. 05	MT
Cantor Fitzgerald Adjusts Price Target on Nyxoah to $14 From $10, Maintains Overweight Rating	Feb. 09	MT
Nyxoah's Preliminary Q4, 2023 Sales Top Consensus; Shares Rise After Hours	Jan. 09	MT
Nyxoah SA Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio(R)	Dec. 11	CI
Nyxoah Appoints Francis Kim as Chief Regulatory, Quality Officer	Nov. 28	MT
Transcript : Nyxoah S.A., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Nyxoah S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Stifel Cuts Nyxoah's Price Target to $10 From $14, Keeps Buy Rating	Nov. 07	MT
Nyxoah, ResMed Germany Team Up to Improve OSA Awareness, Treatment	23-09-28	MT
Transcript : Nyxoah S.A., Q2 2023 Earnings Call, Aug 08, 2023	23-08-08

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah SA's innovative solution platform is based on the Genio® system, a CE-Mark validated, user-centered neurostimulation therapy for obstructive sleep apnea, the world's most common sleep disordered breathing condition.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-14 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Nyxoah SA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

8.4 EUR

Average target price

15.5 EUR

Spread / Average Target

+84.52%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NYXOAH SA	+97.18%	259M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+7.87%	185B
INTUITIVE SURGICAL, INC.	+12.75%	135B
SIEMENS HEALTHINEERS AG	-1.37%	62.21B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.88%	51.01B
EDWARDS LIFESCIENCES CORPORATION	+11.59%	51.28B
AGILENT TECHNOLOGIES, INC.	+2.71%	41.85B
GE HEALTHCARE TECHNOLOGIES INC.	+4.90%	37.02B
RESMED, INC.	+23.75%	31.27B

Other Advanced Medical Equipment & Technology

Nyxoah SA

Equities

NYXH

BE0974358906

Advanced Medical Equipment & Technology

Nyxoah S.A.(NasdaqGM:NYXH) added to NASDAQ Composite Index

Latest news about Nyxoah SA

Chart Nyxoah SA

Company Profile

Income Statement Evolution

Ratings for Nyxoah SA

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology